School of Medicine


Showing 11-20 of 55 Results

  • Dr Rajib Ahmed

    Dr Rajib Ahmed

    Postdoctoral Research Fellow, Radiology

    Bio Dr. Rajib Ahmed working as a postdoc fellow at Stanford University School of Medicine, Canary Center at Stanford for Cancer Early Detection. His research focus on micro- and nano-technologies based biomedical optical devices.

    Rajib received his B.Sc. and M.Sc. degree at the department of applied physics electronics and communication engineering in 2010 and 2012 with first class honor from University of Dhaka (Bangladesh), and also studied two-year double degree M.Sc. as a Erasmus mundus student at MAsters on Photonic NETworks Engineering (MAPNET) on in Scuola Superiore Sant’Anna (Italy), Aston University (UK), and Technische Univeraitat Berlin (Germany) in 2013-2014. He received his Ph.D. degree on laser based nanofabrication from school of engineering, University of Birmingham (UK) in 2018. Upon the completion of his Ph.D. studies, Rajib started working as a postdoctoral research fellow at Stanford University School of Medicine in 2018.

    Rajib has published his research work in the most prestigious journals, including ACS Nano, Scientific Reports, Light: Science & Applications, Advanced Optical Materials, Optics Express, Optics Letter, Nanoscale, RSC Advance. Applied Physics Letter, etc. Besides his research publications, he has contributed to the publication of 3 book chapters. His research findings have been presented in national and international conferences.

  • Marcela Alcantara Hernandez

    Marcela Alcantara Hernandez

    Postdoctoral Research Fellow, Microbiology and Immunology

    Bio My research interest is to understand how human dendritic cell (DC) subsets control immunity and tolerance. Particularly, I am very interested in dissecting how this major immunological axis (i.e., the DC network) contributes to control disease development. I am also interested in developing strategies to harness this immunological axis for the rational design of treatments.

  • Vincent Michael Alford

    Vincent Michael Alford

    Postdoctoral Research Fellow, Stem Cell Biology and Regenerative Medicine

    Current Research and Scholarly Interests My interest in science and research was fostered at a young age after losing a family member to colorectal cancer. At that young age, it was made apparent to me that cancer remains poorly understood which is reflected in the total lack of target-specific treatment regiments available to this patient population. This disparity in patient care is what inspired me to pursue a Ph.D in Molecular and Cellular Pharmacology at Stony Brook University (SBU). During my time at SBU, my dissertation research focused on the development of a standard approach for rational drug design against the functional activity of individual matrix metalloproteinases (MMPs). Results from this work led to the successful development of the first small molecule inhibitor specifically targeting the hemopexin domain of MMP-9. Additionally, I was also given the opportunity to assist in the development of a cell based High-Throughput Screen assay for the identification of small molecules with activity against cancer cell invasion. This work was done in collaboration with large biotechnology companies such as Millipore.

    After obtaining my Ph.D, I pursued a postdoctoral scholar position at Stanford University within the Institute of Stem Cell Biology and Regenerative Medicine. Currently, my projects have slowly become broader and more focused around protein chemistry. More specifically, my research interest lies in identifying protein targets or cell populations responsible for chronic illnesses such as Triple Negative Breast Cancer and Alzheimer’s disease. After identifying the target, my passion lies in understanding the biological function of said target in various biological signaling cascades and cell niche population maintenance. Another area I specialize in is assigning function to the various domains of individual proteins and prioritizing drug development against the most promising targets. Upon identification of the target and validation of the domains responsible for protein activity- it becomes my mission to develop specific inhibitors against them. To this end, I use techniques such as protein mutagenesis, expression, and purification systems in addition to x-ray crystallography and chemical-protein structure activity relationships to understand, rationally design, and optimize these small molecule inhibitors for potential use in clinical trials.